A, S., C, C., R, J., J, H., MA, T., LC, K., . . . B, V. (2024). Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology, 131(12), 1673. https://doi.org/10.1111/1471-0528.17888
Chicago Style (17th ed.) CitationA, Sharp, et al. "Neurodevelopmental Outcomes at 2 years in Children Who Received Sildenafil Therapy In utero: The STRIDER Randomised Controlled Trial." BJOG : An International Journal of Obstetrics and Gynaecology 131, no. 12 (2024): 1673. https://doi.org/10.1111/1471-0528.17888.
MLA (9th ed.) CitationA, Sharp, et al. "Neurodevelopmental Outcomes at 2 years in Children Who Received Sildenafil Therapy In utero: The STRIDER Randomised Controlled Trial." BJOG : An International Journal of Obstetrics and Gynaecology, vol. 131, no. 12, 2024, p. 1673, https://doi.org/10.1111/1471-0528.17888.